Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
about
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationBone Marrow GvHD after Allogeneic Hematopoietic Stem Cell TransplantationTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesModern approaches to HLA-haploidentical blood or marrow transplantationGraft-versus-host disease: why have we not made more progress?Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host diseaseIdiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosisImproving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewHaploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyModeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier DysfunctionMicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.The primary defect in experimental ileitis originates from a nonhematopoietic source.Bone marrow cell graft engineering: from bench to bedside.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Clinical applications of mixed chimerism.Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.Mixed allogeneic chimerism and tolerance to composite tissue allografts.A modified vascularized whole knee joint allotransplantation model in the rat.A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host diseasePreemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.Prevention of lethal murine graft versus host disease by treatment of donor cells with L-leucyl-L-leucine methyl ester.Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin.Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Kinetics of gene expression in murine cutaneous graft-versus-host disease.Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse modelStrategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationPresent and Future of Allogeneic Natural Killer Cell TherapyAcute graft versus host disease following liver transplantation: the enemy within.Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells.Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.Novel expression of vascular cell adhesion molecule-1 (CD106) by squamous epithelium in experimental acute graft-versus-host diseaseHigher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells
P2860
Q24626051-C2888EE1-A68E-44FE-9A53-6736489C37B6Q26749553-D9A9533F-1BF7-4B2B-BF63-064E1AD679F8Q26751959-28A1CDFA-6955-4C9B-B1F0-CDE5E368887FQ26797506-A6AA2BE8-7D88-4262-B681-19FE9B9FF522Q27012940-A59BEBF7-E4AE-4369-B1B8-C88347A694E8Q27314927-81049B1C-88E8-46DE-9DE0-5C5F82736978Q27486642-E7327565-F737-4BB6-BA0C-A902C306B099Q27690246-87CFD8B1-7100-4694-B26D-BBB07ED21D1EQ28066083-595DFC4C-C4BB-4D64-B6BD-CE311635A9E4Q28085397-1CCB75C1-798F-4CE5-A2F1-727651612504Q28550869-A36B152C-192A-45F0-842C-8C3731365173Q30278940-A3D754E3-F069-4EB6-B14C-3DB0F09A02F3Q30439653-7DC0FECB-C0B4-465A-85ED-9C705CE26AABQ30666969-B0AE11D5-387A-47DB-80D3-A9CF3EB5F72BQ33642419-E42FF682-BA22-4800-BAE8-2D170E67262AQ33661943-3E396030-8A8F-4E67-97B1-48185041E4ABQ33749097-0E4F6128-4A36-4F76-8571-07721C6170C2Q33886907-ACD7EA81-448F-48AB-88A1-27B1D5D962F0Q33967995-B40F4F7C-FB4F-4DC8-BF2D-5A553A63C091Q34126623-A5F1492B-D5A7-4F57-8C0C-13A8E314946BQ34208957-08BB5438-1B66-4BEB-84AB-62A59704B728Q34312261-3955317F-8B9A-444D-B60B-DF97411CDD5CQ34408137-AC2D6B63-FCB0-43FB-A0FA-7C12FEB98252Q34489151-C79DED67-55BD-453F-8AC8-5144175B6BF7Q34547736-81918C10-CAFE-48B4-A241-B4B52B812987Q34581469-64311569-67BF-429B-B500-DD70034152FCQ34628320-0D2873E2-BECF-491A-825E-3CD161978C5CQ34632481-ACB1FF32-9F5A-4198-B5BE-8087DAA1248AQ35094029-8EB2C7E2-2535-4726-9E1A-AF3A6EC22F15Q35098314-CA4B944D-A8AA-474C-9993-D6C37F7A041FQ35188151-4D62963E-D3EE-4586-8085-58689846A9BAQ35229872-98E8A3BC-DC7F-4DFC-BBE3-273D44218AF4Q35588845-25074F93-CEC6-47F4-A856-F0836FC67D20Q35677351-08CC748A-1E21-4ADE-B618-DA1AC5E226CCQ35691919-F8F3F55D-D676-41D7-8F30-D1EE3345C546Q35726310-130D64F8-DB4E-4CDF-B251-2167ED2DCCCCQ35750939-304B6358-DFB0-4625-91E8-AF1941275EF4Q35789037-5DAB27AF-FAE2-4A8F-BB9D-CC547DD586FAQ35814424-B3BABA87-FBD6-437C-89DF-D2C3B4F7F12DQ35830507-F2AC1B01-B30B-4D62-8991-8C1972826A28
P2860
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@ast
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@en
type
label
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@ast
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@en
prefLabel
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@ast
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@en
P2860
P356
P1476
Lethal graft-versus-host disea ...... ng mature T cells from marrow.
@en
P2093
P2860
P304
P356
10.1084/JEM.148.6.1687
P407
P577
1978-12-01T00:00:00Z